Predictive Oncology Platform and Utility Protocols (Q11677)

From EU Knowledge Graph
Revision as of 16:17, 28 October 2020 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in 2 languages: Changing unique label-description pair)
Jump to navigation Jump to search
Project Q11677 in Czech Republic
Language Label Description Also known as
English
Predictive Oncology Platform and Utility Protocols
Project Q11677 in Czech Republic

    Statements

    0 references
    0 references
    39,804,511.31 Czech koruna
    0 references
    1,592,180.45 Euro
    10 January 2020
    0 references
    61,769,881.0 Czech koruna
    0 references
    2,470,795.24 Euro
    10 January 2020
    0 references
    64.44 percent
    0 references
    31 October 2020
    0 references
    Institute of Applied Biotechnologies a.s.
    0 references

    50°5'1.93"N, 14°30'28.48"E
    0 references
    10800
    0 references
    10800
    0 references
    Jedná se o projekt vysoké technologické úrovně a vysoké míry inovace, který si klade za cíl významně zvýšit produktový potenciál společnosti Institute of Applied Biotechnologies a.s. (IAB) ve spolupráci s výzkumným partnerem Lékařskou fakultou Univerzity Palackého v Olomouci, jmenovitě Ústavem molekulární a translační medicíny (UMTM). Cílem je vývoj produktů pro prediktivní onkologickou diagnostiku založenou na cirkulujících buňkách / DNA / RNA. a. (Czech)
    0 references
    It is a project of high technological level and high degree of innovation, which aims to significantly increase the product potential of the Institute of Applied Biotechnologies a.s. (IAB) in cooperation with a research partner of the Faculty of Medicine of Palacký University in Olomouc, namely the Institute of Molecular and Translational Medicine (UMTM). The aim is to develop products for predictive oncological diagnostics based on circulating cells/DNA/RNA. a. (English)
    22 October 2020
    0 references

    Identifiers

    CZ.01.1.02/0.0/0.0/17_107/0012422
    0 references